Navidea biopharmaceuticals to present at h.c. wainwright 22nd annual global investment conference

Dublin, ohio--(business wire)--navidea biopharmaceuticals, inc. (nyse american: navb) (“navidea” or the “company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that mr.

NAVB Ratings Summary

NAVB Quant Ranking